Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Disease × Blood Specimen Collection × Clear all

Phase

Phase NA 5 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 3 Neoplasms 3 Sarcoma 2 Lymphoma 2 Uveal Melanoma 1 Thrombosis 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumor, Adult 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pneumothorax 1 Pituitary Neoplasms 1 Philadelphia Chromosome 1 Pathologic Complete Response 1 Pancreatic Neoplasms 1 Oropharyngeal Neoplasms 1 Opioid-Related Disorders 1 Neoplasms, Plasma Cell 1 Neoplasm Metastasis 1 Myelodysplastic Syndromes 1 Metastatic Castration-resistant Prostate Cancer 1 Meningioma 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1 Leukemia, Myeloid, Acute 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia 1 Hodgkin Disease 1 Histiocytosis, Langerhans-Cell 1

Interventions

Dexamethasone 2 vistusertib 1 ricolinostat 1 pomalidomide 1 irinotecan sucrosofate 1 daratumumab 1 bermekimab 1 atezolizumab 1 alovudine 1 TKM-080301 1 TIC10 compound 1 Prostatectomy 1 Pluvicto 1 Magnetic Resonance Spectroscopy 1 Lenalidomide 1 Ipilimumab 1 Ga(III)-DOTATOC 1 Fluorouracil 1 Cyclophosphamide 1 Blood Specimen Collection 1 (225)Ac-PSMA-617 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07054346 2025-12-01

LUTACT

University of California, San Francisco

Phase 1 Recruiting

Disease, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡